Cilia L, Sharbaugh M, Marroquin OC, et al. - Researchers assessed the individual as well as the combined impacts of anemia and chronic kidney disease (CKD) on outcomes of patients with coronary artery disease who underwent percutaneous coronary intervention (PCI) from 2010 to 2018. This study did not include patients with ST-elevation myocardial infarction or shock. Patients with both anemia and CKD had the highest 5-year mortality those who had neither had the lowest. For those with anemia alone, for those with CKD alone, and for those with both anemia and CKD, the estimated adjusted hazard ratio for mortality was 1.68, 1.33, and 2.83, respectively, after multivariate analysis when neither anemia nor CKD group was a reference. Compared with the individual effects, the combined impacts of anemia and CKD on outcomes after PCI seemed to be worse.